CHICAGO—Telmisartan (Micardis HCT), a novel angiotensin receptor blocker (ARB), and the older ARB losartan have similar BP-lowering efficacy in hypertensive patients with diabetic nephropathy ...

In adults with vascular disease but without macroalbuminuria, telmisartan did not improve renal outcomes, and candesartan did not prevent microalbuminuria in normotensive, diabetic patients.

Endothelial dysfunction in the glomeruli and impaired renal autoregulation, which may cause glomerular sclerosis, were observed in DS rat kidney. Telmisartan treatment improves these dysfunctions ...

Telmisartan and enalapril have shown comparable antihypertensive efficacy in nondiabetic hypertensive patients and similar efficacy in reducing proteinuria in patients with moderate renal failure.

For the secondary renal outcome, dialysis or doubling of serum creatine, 189 events were recorded in the telmisartan group, compared with 174 in the ramipril group, but 212 in the combination group.

A combination of ramipril (Altace) 10 mg daily plus telmisartan (Micardis) 80 mg daily does not reduce mortality or cardiovascular morbidity compared with ramipril alone, based on a randomized ...

For patients with lower-extremity peripheral artery disease (PAD), telmisartan does not improve six-minute walk distance compared with placebo at six-month follow-up, according to a study ...

Telmisartan, a drug widely used to help control blood pressure, may have uniquely potent activity in preventing stroke, according to a new study conducted in an animal model.

Therapy with telmisartan initiated soon after an ischemic stroke and continued for 2.5 years did not significantly lower the rate of recurrent stroke, major cardiovascular events, or diabetes.

Alembic Pharmaceuticals has recalled one lot of 20mg telmisartan tablets because the bottles may actually contain 40mg tablets. This photo shows the oval-shaped 40mg tablets.

To the Editor: Barnett et al. (Nov. 4 issue)1 compared telmisartan and enalapril in type 2 diabetic nephropathy, without reporting or adjusting for certain major risk factors associated with diabe ...